Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bioverativ
Pharma
Sanofi buys Blueprint for $9.1B, its largest deal in 7 years
After signaling its intent to make "bolt-on acquisitions," Sanofi has taken a major plunge, buying out Blueprint Medicines for $9.5 billion.
Kevin Dunleavy
Jun 2, 2025 11:09am
Say hello to Viatris: Pfizer's Upjohn, Mylan merger gets a name
Nov 12, 2019 2:32pm
Sanofi takes $2B hemophilia write-down
Jul 29, 2019 11:51am
Sanofi EVP's Bioverativ blabbing ends in insider trading suits
Jun 14, 2019 10:15am
Sanofi's Eloctate suffers on Roche's Hemlibra launch
Apr 26, 2019 12:23pm
Cablivi is Sanofi’s first approval from Ablynx buyout
Feb 6, 2019 12:23pm
